Petit JM - Search Results

1

Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study).

Nabi O, Lapidus N, Boursier J, de Ledinghen V, Petit JM, Kab S, Renuy A, Zins M, Lacombe K, Serfaty L. Nabi O, et al. Among authors: petit jm. Hepatology. 2023 Jul 1;78(1):272-283. doi: 10.1097/HEP.0000000000000329. Epub 2023 Feb 24. Hepatology. 2023. PMID: 36815354

2

Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLD.

Nabi O, Lapidus N, Boursier J, de Ledinghen V, Petit JM, Kab S, Renuy A, Zins M, Lacombe K, Serfaty L. Nabi O, et al. Among authors: petit jm. Hepatology. 2024 May 1;79(5):E130-E131. doi: 10.1097/HEP.0000000000000755. Epub 2024 Jan 22. Hepatology. 2024. PMID: 38252803 No abstract available.

3

A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease.

Romero-Gómez M, Lawitz E, Shankar RR, Chaudhri E, Liu J, Lam RLH, Kaufman KD, Engel SS; MK-6024 P001 Study Group. Romero-Gómez M, et al. J Hepatol. 2023 Oct;79(4):888-897. doi: 10.1016/j.jhep.2023.05.013. Epub 2023 Jun 22. J Hepatol. 2023. PMID: 37355043 Free article. Clinical Trial.

4

Heterozygous pathogenic variants in POMC are not responsible for monogenic obesity: Implication for MC4R agonist use.

Le Collen L, Delemer B, Poitou C, Vaxillaire M, Toussaint B, Dechaume A, Badreddine A, Boissel M, Derhourhi M, Clément K, Petit JM, Mau-Them FT, Bruel AL, Thauvin-Robinet C, Saveanu A, Cherifi BG, Le Beyec-Le Bihan J, Froguel P, Bonnefond A. Le Collen L, et al. Among authors: petit jm. Genet Med. 2023 Jul;25(7):100857. doi: 10.1016/j.gim.2023.100857. Epub 2023 Apr 21. Genet Med. 2023. PMID: 37092539

5

Plasma 16:0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes.

Denimal D, Duvillard L, Béland-Bonenfant S, Terriat B, Pais-de-Barros JP, Simoneau I, Rouland A, Houbachi L, Bouillet B, Vergès B, Petit JM. Denimal D, et al. Among authors: petit jm. Diabetes Metab. 2024 May 4;50(4):101542. doi: 10.1016/j.diabet.2024.101542. Online ahead of print. Diabetes Metab. 2024. PMID: 38710301

6

No effect of liraglutide on high density lipoprotein apolipoprotein AI kinetics in patients with type 2 diabetes.

Duvillard L, Pais de Barros JP, Rouland A, Simoneau I, Denimal D, Bouillet B, Petit JM, Vergès B. Duvillard L, et al. Among authors: petit jm. Diabetes Metab. 2024 May;50(3):101535. doi: 10.1016/j.diabet.2024.101535. Epub 2024 Apr 21. Diabetes Metab. 2024. PMID: 38653365 Free article.

7

Screening and management of metabolic complications of mTOR inhibitors in real-life settings.

Spanjaard P, Petit JM, Schmitt A, Vergès B, Bouillet B. Spanjaard P, et al. Among authors: petit jm. Ann Endocrinol (Paris). 2023 Dec 1:S0003-4266(23)00744-8. doi: 10.1016/j.ando.2023.11.003. Online ahead of print. Ann Endocrinol (Paris). 2023. PMID: 38043912

8

Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes.

Denimal D, Béland-Bonenfant S, Pais-de-Barros JP, Rouland A, Bouillet B, Duvillard L, Vergès B, Petit JM. Denimal D, et al. Among authors: petit jm. Cardiovasc Diabetol. 2023 Nov 8;22(1):310. doi: 10.1186/s12933-023-02049-2. Cardiovasc Diabetol. 2023. PMID: 37940926 Free PMC article.

9

Impact of a Tripartite Collaboration between Oncologist, Pharmacist and Diabetologist in the Management of Patients with Diabetes Starting Chemotherapy: The ONCODIAB Trial.

Paris J, Legris P, Devaux M, Bost S, Gueneau P, Rossi C, Manfredi S, Bouillet B, Petit JM, Pistre P, Boulin M. Paris J, et al. Among authors: petit jm. Cancers (Basel). 2023 Sep 13;15(18):4544. doi: 10.3390/cancers15184544. Cancers (Basel). 2023. PMID: 37760514 Free PMC article.

10

Inflammation and oxidative stress markers in type 2 diabetes patients with Advanced Carotid atherosclerosis.

Ménégaut L, Laubriet A, Crespy V, Leleu D, Pilot T, Van Dongen K, de Barros JP, Gautier T, Petit JM, Thomas C, Nguyen M, Steinmetz E, Masson D. Ménégaut L, et al. Among authors: petit jm. Cardiovasc Diabetol. 2023 Sep 14;22(1):248. doi: 10.1186/s12933-023-01979-1. Cardiovasc Diabetol. 2023. PMID: 37710315 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

597 results

Search Page